Notably, however, other studies suggested that SMAD4mut cancer cells might benefit from SMAD4-independent TGFβ/BMP receptor-driven signaling to undergo EMT-like changes [47, 48], arguing for further complexity and plasticity among the routes to EMT in SMAD4mut tumors. This evidence concerns the gene TGFB1 and cancer.